The World Health Organization (WHO) has approved the Chinese vaccine Sinopharm for immediate use.
The World Health Organization (WHO) has approved the emergency use of the “Sinopharm” vaccine developed by China.
WHO Director-General Tedros Adhanom Ghebreyesus held a press conference at the organization’s headquarters in Geneva.
Ghebreyesus stated that the WHO has authorized the “Sinopharm” vaccine developed by China for immediate use this afternoon, adding that it is the 6th Covid-19 vaccine that has received WHO’s emergency use approval for “safety, efficacy, and quality”.
Ghebreyesus stressed that this approval expands the list of vaccines of the Covid-19 Vaccines Global Access Program (COVAX) and gives countries confidence to import and implement this vaccine with emergency use approval within themselves.
Ghebreyesus said that the Advisory Group of Strategic Experts (SAGE), which advises the WHO on the use of Covid-19 vaccines, is reviewing existing data on the vaccine, and that it is recommended that the vaccine be administered in two doses for adults 18 years and older.
It first approved the emergency use of the Covid-19 vaccine produced by Pfizer-BioNTech on December 31st.
The WHO later approved the Oxford-AstraZeneca vaccine, the vaccine produced by AstraZeneca’s vaccine manufacturer, the Serum Institute of India (SII), and the vaccines produced by Moderna and Janssen.